Skip to content

BT-001 Diabetes Digital Therapeutic Device

by Better Therapeutics

De Novo DEN220058

Active United States

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Source FDA De Novo, synced 6 Oct 2026.

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA De NovoDENG De Novo granted · Direct NumberDEN220058 Date7 Jul 2023DecidedStatusActive

Official records

From the FDA record

Received by the FDA
21 Sep 2022
FDA decision
7 Jul 2023
FDA review time
289 days from receipt to decision

From the FDA De Novo record DEN220058 (openFDA), as read on 6 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

De Novo

Full name
Bt-001
De Novo Number
FDA product code
QXC
Device class
Class II
Regulation
21 CFR Part 880.5735
Advisory committee
General Hospital
FDA decision
DENG De Novo granted

Overview

AI-generated summary, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Bt-001 Diabetes Digital Therapeutic Device is a prescription-only digital therapeutic device that provides cognitive behavioral therapy to patients 18 years or older with type 2 diabetes. It is intended to be used adjunctively with standard of care. The device is classified as a class 2 device with the regulation number 880.5735.

The Bt-001 is supplied as a single device and is indicated for use in patients with type 2 diabetes. It is authorized by the FDA with a 510K clearance. The device is used in a general hospital setting and has a product code of QXC. The device is for single use and is not specified as MRI safe or sterile in the provided data.

Devices cleared under DEN220058

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under DEN220058
UDI-DISize and differences
AspyreRx ma.1.0.0
Better Therapeutics
ma.1.0.000860011146704 —On the market

Other devices from Better Therapeutics

  • AspyreRx ma.1.0.0

    Class II